Potentially novel candidate biomarkers for head and neck squamous cell carcinoma identified using an integrated cell line-based discovery strategy

Molecular and Cellular Proteomics

Volumn 11, Issue 11, 2012, Pages 1404-1415

  Sepiashvili, Lusia ^a,b   Hui, Angela ^b   Ignatchenko, Vladimir ^b   Shi, Willa ^b   Su, Susie ^c   Xu, Wei ^c   Huang, Shao Hui ^a   O'Sullivan, Brian ^a   Waldron, John ^a   Irish, Jonathan C ^c   Perez Ordonez, Bayardo ^a   Liu, Fei Fei ^a,b   Kislinger, Thomas ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; INSULIN LIKE GROWTH FACTOR BINDING PROTEIN 7; MATRIX METALLOPROTEINASE 14; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; UROKINASE;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; FEMALE; GENE PRODUCT; GENETIC TRANSCRIPTION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HYPOPHARYNX CARCINOMA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELL LINE, TUMOR; DATA MINING; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84869206978     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M112.020933     Document Type: Article

References (54)

1. Leemans, C. R., Braakhuis, B. J., and Brakenhoff, R. H. (2011) The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9-22
2. Matta, A., Ralhan, R., DeSouza, L. V., and Siu, K. W. (2010) Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery. Mass Spectrom. Rev. 29, 945-961
3. Schaaij-Visser, T. B., Brakenhoff, R. H., Leemans, C. R., Heck, A. J., and Slijper, M. (2010) Protein biomarker discovery for head and neck cancer. J. Proteomics 73, 1790-1803
4. de Jong, M. C., Pramana, J., Knegjens, J. L., Balm, A. J., van den Brekel, M. W., Hauptmann, M., Begg, A. C., and Rasch, C. R. (2010) HPV and high-risk gene expression profiles predict response to chemoradiotherapy in head and neck cancer, independent of clinical factors. Radiother. Oncol. 95, 365-370
5. Tabor, M. P., Brakenhoff, R. H., Ruijter-Schippers, H. J., Kummer, J. A., Leemans, C. R., and Braakhuis, B. J. (2004) Genetically altered fields as origin of locally recurrent head and neck cancer: a retrospective study. Clin. Cancer Res. 10, 3607-3613 (Pubitemid 38697593)
6. Poeta, M. L., Manola, J., Goldwasser, M. A., Forastiere, A., Benoit, N., Califano, J. A., Ridge, J. A., Goodwin, J., Kenady, D., Saunders, J., Westra, W., Sidransky, D., and Koch, W. M. (2007) TP53 mutations and survival in squamous-cell carcinoma of the head and neck. N. Engl. J. Med. 357, 2552-2561 (Pubitemid 350294222)
7. Ang, K. K., Harris, J., Wheeler, R., Weber, R., Rosenthal, D. I., Nguyen-Tân, P. F., Westra, W. H., Chung, C. H., Jordan, R. C., Lu, C., Kim, H., Axelrod, R., Silverman, C. C., Redmond, K. P., and Gillison, M. L. (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med. 363, 24-35
8. Shi, W., Kato, H., Perez-Ordonez, B., Pintilie, M., Huang, S., Hui, A., O'Sullivan, B., Waldron, J., Cummings, B., Kim, J., Ringash, J., Dawson, L. A., Gullane, P., Siu, L., Gillison, M., and Liu, F. F. (2009) Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J. Clin. Oncol. 27, 6213-6221
9. Bonner, J. A., Harari, P. M., Giralt, J., Cohen, R. B., Jones, C. U., Sur, R. K., Raben, D., Baselga, J., Spencer, S. A., Zhu, J., Youssoufian, H., Rowinsky, E. K., and Ang, K. K. (2010) Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol. 11, 21-28
10. Tonack, S., Aspinall-O'Dea, M., Jenkins, R. E., Elliot, V., Murray, S., Lane, C. S., Kitteringham, N. R., Neoptolemos, J. P., and Costello, E. (2009) A technically detailed and pragmatic protocol for quantitative serum proteomics using iTRAQ. J. Proteomics 73, 352-356
11. Kulasingam, V., and Diamandis, E. P. (2007) Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol. Cell. Proteomics 6, 1997-2011 (Pubitemid 350201873)
12. Wu, C. C., Hsu, C. W., Chen, C. D., Yu, C. J., Chang, K. P., Tai, D. I., Liu, H. P., Su, W. H., Chang, Y. S., and Yu, J. S. (2010) Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol. Cell. Proteomics 9, 1100-1117
13. Sardana, G., Jung, K., Stephan, C., and Diamandis, E. P. (2008) Proteomic analysis of conditioned media from the PC3, LNCaP, and 22Rv1 prostate cancer cell lines: discovery and validation of candidate prostate cancer biomarkers. J. Proteome Res. 7, 3329-3338
14. Gunawardana, C. G., Kuk, C., Smith, C. R., Batruch, I., Soosaipillai, A., and Diamandis, E. P. (2009) Comprehensive analysis of conditioned media from ovarian cancer cell lines identifies novel candidate markers of epithelial ovarian cancer. J. Proteome Res. 8, 4705-4713
15. Makridakis, M., and Vlahou, A. (2010) Secretome proteomics for discovery of cancer biomarkers. J. Proteomics 73, 2291-2305
16. Planque, C., Kulasingam, V., Smith, C. R., Reckamp, K., Goodglick, L., and Diamandis, E. P. (2009) Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines. Mol. Cell. Proteomics 8, 2746-2758
17. Du, B., Wang, P., Guo, X., and Du, B. (1999) Expression of membrane type 1-matrix metalloproteinase in laryngeal carcinoma. Pathol. Oncol. Res. 5, 214-217 (Pubitemid 29510776)
18. Faça, V. M., Ventura, A. P., Fitzgibbon, M. P., Pereira-Faca, S. R., Pitteri, S. J., Green, A. E., Ireton, R. C., Zhang, Q., Wang, H., O'Briant, K. C., Drescher, C. W., Schummer, M., McIntosh, M. W., Knudsen, B. S., and Hanash, S. M. (2008) Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains. PloS One 3, e2425
19. Faça, V. M., and Hanash, S. M. (2009) In-depth proteomics to define the cell surface and secretome of ovarian cancer cells and processes of protein shedding. Cancer Res. 69, 728-730
20. Loei, H., Tan, H. T., Lim, T. K., Lim, K. H., So, J. B., Yeoh, K. G., and Chung, M. C. (2012) Mining the Gastric Cancer Secretome: Identification of GRN as a Potential Diagnostic Marker for Early Gastric Cancer. J. Proteome Res. 11, 1759-1772
21. Washburn, M. P., Wolters, D., and Yates, J. R., 3rd (2001) Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247 (Pubitemid 32220565)
22. Taylor, P., Nielsen, P. A., Trelle, M. B., Hørning, O. B., Andersen, M. B., Vorm, O., Moran, M. F., and Kislinger, T. (2009) Automated 2D peptide separation on a 1D nano-LC-MS system. J. Proteome Res. 8, 1610-1616
23. Hui, A. B., Lenarduzzi, M., Krushel, T., Waldron, L., Pintilie, M., Shi, W., Perez-Ordonez, B., Jurisica, I., O'Sullivan, B., Waldron, J., Gullane, P., Cummings, B., and Liu, F. F. (2010) Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin. Cancer Res. 16, 1129-1139
24. Gortzak-Uzan, L., Ignatchenko, A., Evangelou, A. I., Agochiya, M., Brown, K. A., St Onge, P., Kireeva, I., Schmitt-Ulms, G., Brown, T. J., Murphy, J., Rosen, B., Shaw, P., Jurisica, I., and Kislinger, T. (2008) A proteome resource of ovarian cancer ascites: integrated proteomic and bioinformatic analyses to identify putative biomarkers. J. Proteome Res. 7, 339-351 (Pubitemid 351171148)
25. Sodek, K. L., Evangelou, A. I., Ignatchenko, A., Agochiya, M., Brown, T. J., Ringuette, M. J., Jurisica, I., and Kislinger, T. (2008) Identification of pathways associated with invasive behavior by ovarian cancer cells using multidimensional protein identification technology (MudPIT). Mol. Biosyst. 4, 762-773 (Pubitemid 351871749)
26. Emanuelsson, O., Brunak, S., von Heijne, G., and Nielsen, H. (2007) Locating proteins in the cell using TargetP, SignalP and related tools. Nat. Protocols 2, 953-971 (Pubitemid 46745592)
27. Mathivanan, S., and Simpson, R. J. (2009) ExoCarta: A compendium of exosomal proteins and RNA. Proteomics 9, 4997-5000
28. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408 (Pubitemid 34164012)
29. Kuriakose, M. A., Chen, W. T., He, Z. M., Sikora, A. G., Zhang, P., Zhang, Z. Y., Qiu, W. L., Hsu, D. F., McMunn-Coffran, C., Brown, S. M., Elango, E. M., Delacure, M. D., and Chen, F. A. (2004) Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol. Life Sci. 61, 1372-1383 (Pubitemid 38822426)
30. Cromer, A., Carles, A., Millon, R., Ganguli, G., Chalmel, F., Lemaire, F., Young, J., Dembélé, D., Thibault, C., Muller, D., Poch, O., Abecassis, J., and Wasylyk, B. (2004) Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23, 2484-2498 (Pubitemid 38520746)
31. Kulasingam, V., Zheng, Y., Soosaipillai, A., Leon, A. E., Gion, M., and Diamandis, E. P. (2009) Activated leukocyte cell adhesion molecule: a novel biomarker for breast cancer. Int. J. Cancer 125, 9-14
32. Xue, H., Lü, B., Zhang, J., Wu, M., Huang, Q., Wu, Q., Sheng, H., Wu, D., Hu, J., and Lai, M. (2010) Identification of serum biomarkers for colorectal cancer metastasis using a differential secretome approach. J. Proteome Res. 9, 545-555
33. Schafer, J. M., Peters, D. E., Morley, T., Liu, S., Molinolo, A. A., Leppla, S. H., and Bugge, T. H. (2011) Efficient targeting of head and neck squamous cell carcinoma by systemic administration of a dual uPA and MMP-activated engineered anthrax toxin. PloS One 6, e20532
34. Yasuda, T., Sakata, Y., Kitamura, K., Morita, M., and Ishida, T. (1997) Localization of plasminogen activators and their inhibitor in squamous cell carcinomas of the head and neck. Head Neck 19, 611-616 (Pubitemid 27407316)
35. Myoung, H., Kim, M. J., Hong, S. D., Lee, J. I., Lim, C. Y., and Hong, S. P. (2002) Expression of membrane type I-matrix metalloproteinase in oral squamous cell carcinoma. Cancer letters 185, 201-209
36. Shiomi, T., and Okada, Y. (2003) MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev. 22, 145-152 (Pubitemid 36561054)
37. Zhang, H., Liu, M., Sun, Y., and Lu, J. (2009) MMP-14 can serve as a prognostic marker in patients with supraglottic cancer. Eur. Arch. Otorhinolaryngol. 266, 1427-1434
38. Suojanen, J., Salo, T., Koivunen, E., Sorsa, T., and Pirila, E. (2009) A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth. Cancer Biol. Ther. 8, 2362-2370
39. de Vicente, J. C., Lequerica-Fernandez, P., Santamaria, J., and Fresno, M. F. (2007) Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J. Oral. Pathol. Med. 36, 415-424 (Pubitemid 47037904)
40. Rosenthal, E. L., and Matrisian, L. M. (2006) Matrix metalloproteases in head and neck cancer. Head Neck 28, 639-648 (Pubitemid 44025114)
41. Imanishi, Y., Fujii, M., Tokumaru, Y., Tomita, T., Kanke, M., Kanzaki, J., Kameyama, K., Otani, Y., and Sato, H. (2000) Clinical significance of expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 in human head and neck squamous cell carcinoma. Human Pathol. 31, 895-904
42. Kurahara, S., Shinohara, M., Ikebe, T., Nakamura, S., Beppu, M., Hiraki, A., Takeuchi, H., and Shirasuna, K. (1999) Expression of MMPS, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 21, 627-638 (Pubitemid 29459868)
43. Parolini, S., Flagiello, D., Cinquetti, A., Gozzi, R., Cristini, S., Cappiello, J., Nicolai, P., Rusnati, M., Presta, M., and Tosatti, M. M. (1996) Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx. Br. J. Cancer 74, 1168-1174 (Pubitemid 26361038)
44. Strojan, P., Budihna, M., Smid, L., Vrhovec, I., and Skrk, J. (1998) Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients. Eur. J. Cancer 34, 1193-1197 (Pubitemid 28342108)
45. Pasini, F. S., Brentani, M. M., Kowalski, L. P., and Federico, M. H. (2001) Transforming growth factor beta1, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 mRNA expression in head and neck squamous carcinoma and normal adjacent mucosa. Head Neck 23, 725-732 (Pubitemid 32751488)
46. Zhang, Z., Pan, J., Li, L., Wang, Z., Xiao, W., and Li, N. (2011) Survey of risk factors contributed to lymphatic metastasis in patients with oral tongue cancer by immunohistochemistry. J. Oral. Pathol. Med. 40, 127-134
47. Dass, K., Ahmad, A., Azmi, A. S., Sarkar, S. H., and Sarkar, F. H. (2008) Evolving role of uPA/uPAR system in human cancers. Cancer Treatment Rev. 34, 122-136
48. Chen, D., Yoo, B. K., Santhekadur, P. K., Gredler, R., Bhutia, S. K., Das, S. K., Fuller, C., Su, Z. Z., Fisher, P. B., and Sarkar, D. (2011) Insulin-like growth factor-binding protein-7 functions as a potential tumor suppressor in hepatocellular carcinoma. Clin. Cancer Res. 17, 6693-6701
49. Shersher, D. D., Vercillo, M. S., Fhied, C., Basu, S., Rouhi, O., Mahon, B., Coon, J. S., Warren, W. H., Faber, L. P., Hong, E., Bonomi, P., Liptay, M. J., and Borgia, J. A. (2011) Biomarkers of the insulin-like growth factor pathway predict progression and outcome in lung cancer. Annals Thoracic Surg. 92, 1805-1811; discussion 1811
50. Hwa, V., Oh, Y., and Rosenfeld, R. G. (1999) Insulin-like growth factor binding proteins: a proposed superfamily. Acta Paediatr. Suppl. 88, 37-45 (Pubitemid 29108402)
51. Vizioli, M. G., Possik, P. A., Tarantino, E., Meissl, K., Borrello, M. G., Miranda, C., Anania, M. C., Pagliardini, S., Seregni, E., Pierotti, M. A., Pilotti, S., Peeper, D. S., and Greco, A. (2011) Evidence of oncogene-induced senescence in thyroid carcinogenesis. Endocrine-related Cancer 18, 743-757
52. Albo, D., and Tuszynski, G. P. (2004) Thrombospondin-1 up-regulates tumor cell invasion through the urokinase plasminogen activator receptor in head and neck cancer cells. J. Surg. Res. 120, 21-26 (Pubitemid 38686526)
53. Ralhan, R., Masui, O., Desouza, L. V., Matta, A., Macha, M., and Siu, K. W. (2011) Identification of proteins secreted by head and neck cancer cell lines using LC-MS/MS: Strategy for discovery of candidate serological biomarkers. Proteomics 11, 2363-2376
54. Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., Varela, I., Phillimore, B., Begum, S., McDonald, N. Q., Butler, A., Jones, D., Raine, K., Latimer, C., Santos, C. R., Nohadani, M., Eklund, A. C., Spencer-Dene, B., Clark, G., Pickering, L., Stamp, G., Gore, M., Szallasi, Z., Downward, J., Futreal, P. A., and Swanton, C. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892